Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-carnitine in Septic Shock
NCT00592488Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Aug 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetyl-l-carnitine in septic shock (2 arms), sponsored by Vanderbilt University. Primary endpoint: Mean Arterial Blood Pressure at 18 hours. Started Aug 2006; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00592488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592488.